Core Group members


Core Group Members

The following Core Group members represent the various sub-specialities that encounter patients at risk of VTE.

  • Giancarlo Agnelli

  • Professor of Internal Medicine, University of Perugia, Director of the Department of Internal and Cardiovascular Medicine and Stroke-Unit at the University Hospital in Perugia, Italy. 
  • Juan I. Arcelus Professor of Surgery, Department of Surgery, University of Granada Medical School, Hospital Universitario Virgen de las Nieves, Granada, Spain              
  • Claudio Cimminiello Director, Internal Medicine Department, Vimercate Hospital, Vimercate, Milan, Italy
  • Alexander (Ander) T. Cohen Consultant Physician and Epidemiologist, Department of Haematology, Guy's and St Thomas' Hospitals NHS Foundation Trust and King’s College London, London UK
  • Ola E. Dahl Executive Director of International Surgical Thrombosis Forum (ISTF)
  • Ian A. Greer Dean/Professor of Obstetric Medicine, Hull York Medical School, University of York, York, UK

David Jiménez

Associate Professor of Medicine, University of Alcalá de Henares, Madrid, Spain

  • Stavros V. Konstantinides Professor of Medicine, Vice-Chairman, Department of Cardiology and Pulmonary Medicine, Georg August University of Göttingen, Göttingen, Germany
  • Mario Mandalà Medical Oncologist/Clinical Assistant, Unit of Medical Oncology, Riuniti Bergamo Hospital, Bergamo, Italy
  • Serge Motte Clinical Professor, Department of Vascular Diseases, Free University of Brussels (ULB), and University Clinics of Brussels, Erasmus Hospital, Brussels, Belgium
  • Simon Noble

  • Marie Curie Professor in Supportive and Palliative Medicine, Cardiff University School of Medicine, Cardiff, Wales
  • Andrew Peacock Consultant Respiratory Physician, Scottish Pulmonary Vascular Unit, Glasgow, UK
  • Lars Hvilsted Rasmussen Head of Cardiology and the Thrombosis Research Unit, Heart Centre Aalborg, Århus University Hospital, Aalborg Hospital, Århus, Denmark
  • Hans-Joachim Schmoll Professor and Head of the Department of Haematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany
  • Daniel J. Sereni Professor of Medicine, University of Paris and Saint-Louis Hospital, Paris, France
  • Adam Torbicki Professor of Medicine/Head, Department of Chest Medicine, Institute of Tuberculosis and Lung Diseases, Medical University of Warsaw, Warsaw, Poland
© 2012 VTE   |   Disclaimer